Contraindications and Special Populations

A contraindication is a circumstance in which a medicine should not be used because the risk of harm outweighs any benefit. Special populations — older adults, children, pregnant or breastfeeding people, and those with renal or hepatic impairment — alter how drugs are handled and tolerated, so the conditions under which a medicine is unsafe shift with the patient. This topic concerns how those conditions are conceptualised and catalogued.

Definition

A contraindication is a patient condition or circumstance that makes the use of a particular medicine inadvisable because expected harm exceeds expected benefit; special populations are patient groups whose altered physiology systematically changes the risk-benefit balance of medicines.

Scope

The topic covers the meaning of absolute and relative contraindications, the physiological reasons special populations carry altered risk, and reference frameworks such as potentially-inappropriate-medication criteria and renal dose adjustment. It is framed as a reference and educational topic describing concepts and surveillance frameworks; it provides no individualised prescribing, dosing, or treatment advice.

Core questions

• What distinguishes an absolute from a relative contraindication?
• Why do altered physiology and organ function change which drugs are unsafe in special populations?
• How are potentially inappropriate medications identified for vulnerable groups?
• How do system-level tools support safer prescribing where contraindications are common?

Key concepts

• Absolute versus relative contraindication
• Risk-benefit balance
• Potentially inappropriate medication
• Polypharmacy
• Renal and hepatic dose considerations
• Pregnancy and lactation risk
• Pharmacokinetic and pharmacodynamic change with age

Mechanisms

Contraindications arise where a drug's pharmacology intersects with a patient condition to make harm likely — for example, an agent that impairs an already compromised organ, or one that interacts dangerously with a coexisting therapy. Special populations carry altered risk because pharmacokinetics (absorption, distribution, metabolism, excretion) and pharmacodynamics change: reduced renal clearance raises exposure to renally eliminated drugs, hepatic impairment alters metabolism, ageing changes drug sensitivity, and pregnancy introduces a second exposed individual. Reference frameworks operationalise these risks: the Beers Criteria catalogue medications potentially inappropriate in older adults (AGS 2023), and decision support can guide adjustment in renal impairment (Chertow 2001). Type A reactions tied to known pharmacology are especially relevant where exposure is elevated (Edwards & Aronson 2000).

Clinical relevance

Contraindications and special-population considerations are central to interpreting drug-safety information and to the literature on potentially inappropriate prescribing, which links such medicines to adverse outcomes in older adults (AGS 2023). The material is presented descriptively to explain concepts and reference frameworks; it is educational and not a source of individualised prescribing or dosing guidance.

Epidemiology

Older adults bear a disproportionate share of drug-related harm owing to polypharmacy and altered physiology, motivating explicit criteria for potentially inappropriate medications (AGS 2023). Patients with renal insufficiency frequently receive doses that do not account for reduced clearance, and structured guidance has been shown in trial settings to improve dosing appropriateness (Chertow 2001). These patterns make special populations a recurrent focus of medication-safety research.

History

The notion of cataloguing medicines unsafe for a defined group was crystallised by Mark Beers, whose criteria for potentially inappropriate medication use in older adults were first published in 1991 and have been periodically updated by the American Geriatrics Society (AGS 2023). Parallel work integrated renal-function-aware decision support into prescribing (Chertow 2001), and the broader classification of dose-dependent reactions framed why elevated exposure in special populations matters (Edwards & Aronson 2000).

Debates

How should potentially-inappropriate-medication criteria be used?

Explicit lists such as the Beers Criteria standardise the identification of higher-risk medicines in older adults, but they are screening references rather than absolute prohibitions, and applying them without individual context risks both under- and over-restriction.

Key figures

• Mark Beers
• Donna Fick
• Glenn Chertow

Seminal works

• ags-beers-2023
• chertow-2001

Frequently asked questions

What is the difference between an absolute and a relative contraindication?

An absolute contraindication means a medicine should not be used at all in that circumstance, whereas a relative contraindication means it may be used with caution when the expected benefit outweighs the heightened risk.

Why are older adults considered a special population for medication safety?

Age-related changes in organ function and drug sensitivity, combined with polypharmacy, raise the risk of harm, which is why reference criteria identify medications that are potentially inappropriate in this group.